دورية أكاديمية

Reinventing the Penumbra - the Emerging Clockwork of a Multi-modal Mechanistic Paradigm.

التفاصيل البيبلوغرافية
العنوان: Reinventing the Penumbra - the Emerging Clockwork of a Multi-modal Mechanistic Paradigm.
المؤلفون: Walther J; Charité - Universitätsmedizin Berlin, Department of Neurology with Experimental Neurology, Charitéplatz 1, 10117, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Center for Stroke Research Berlin, Charitéplatz 1, 10117, Berlin, Germany., Kirsch EM; Charité - Universitätsmedizin Berlin, Department of Neurology with Experimental Neurology, Charitéplatz 1, 10117, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Center for Stroke Research Berlin, Charitéplatz 1, 10117, Berlin, Germany., Hellwig L; Charité - Universitätsmedizin Berlin, Department of Neurology with Experimental Neurology, Charitéplatz 1, 10117, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Center for Stroke Research Berlin, Charitéplatz 1, 10117, Berlin, Germany., Schmerbeck SS; Charité - Universitätsmedizin Berlin, Department of Neurology with Experimental Neurology, Charitéplatz 1, 10117, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Center for Stroke Research Berlin, Charitéplatz 1, 10117, Berlin, Germany., Holloway PM; Acute Stroke Programme, Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 9DU, UK., Buchan AM; Charité - Universitätsmedizin Berlin, Center for Stroke Research Berlin, Charitéplatz 1, 10117, Berlin, Germany. alastair.buchan@medsci.ox.ac.uk.; Acute Stroke Programme, Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 9DU, UK. alastair.buchan@medsci.ox.ac.uk., Mergenthaler P; Charité - Universitätsmedizin Berlin, Department of Neurology with Experimental Neurology, Charitéplatz 1, 10117, Berlin, Germany. philipp.mergenthaler@charite.de.; Charité - Universitätsmedizin Berlin, Center for Stroke Research Berlin, Charitéplatz 1, 10117, Berlin, Germany. philipp.mergenthaler@charite.de.; Charité - Universitätsmedizin Berlin, NeuroCure Clinical Research Center, Charitéplatz 1, 10117, Berlin, Germany. philipp.mergenthaler@charite.de.; Acute Stroke Programme, Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 9DU, UK. philipp.mergenthaler@charite.de.
المصدر: Translational stroke research [Transl Stroke Res] 2023 Oct; Vol. 14 (5), pp. 643-666. Date of Electronic Publication: 2022 Oct 11.
نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 101517297 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1868-601X (Electronic) Linking ISSN: 18684483 NLM ISO Abbreviation: Transl Stroke Res Subsets: MEDLINE
أسماء مطبوعة: Original Publication: New York : Springer
مواضيع طبية MeSH: Stroke*/metabolism , Brain Ischemia*/metabolism, Humans ; Brain/metabolism ; Glucose ; Oxygen/metabolism
مستخلص: The concept of the ischemic penumbra was originally defined as the area around a necrotic stroke core and seen as the tissue at imminent risk of further damage. Today, the penumbra is generally considered as time-sensitive hypoperfused brain tissue with decreased oxygen and glucose availability, salvageable tissue as treated by intervention, and the potential target for neuroprotection in focal stroke. The original concept entailed electrical failure and potassium release but one short of neuronal cell death and was based on experimental stroke models, later confirmed in clinical imaging studies. However, even though the basic mechanisms have translated well, conferring brain protection, and improving neurological outcome after stroke based on the pathophysiological mechanisms in the penumbra has yet to be achieved. Recent findings shape the modern understanding of the penumbra revealing a plethora of molecular and cellular pathophysiological mechanisms. We now propose a new model of the penumbra, one which we hope will lay the foundation for future translational success. We focus on the availability of glucose, the brain's central source of energy, and bioenergetic failure as core pathophysiological concepts. We discuss the relation of mitochondrial function in different cell types to bioenergetics and apoptotic cell death mechanisms, autophagy, and neuroinflammation, to glucose metabolism in what is a dynamic ischemic penumbra.
(© 2022. The Author(s).)
References: Mol Cell. 2019 Jun 6;74(5):909-921.e6. (PMID: 31006538)
Trends Neurosci. 1999 Sep;22(9):391-7. (PMID: 10441299)
Nat Med. 2009 Sep;15(9):1031-7. (PMID: 19718040)
Nat Rev Immunol. 2015 Oct;15(10):599-614. (PMID: 26403194)
Stroke. 1981 Nov-Dec;12(6):723-5. (PMID: 6272455)
Stroke. 2011 Jan;42(1 Suppl):S7-11. (PMID: 21164112)
Stroke. 1977 Jan-Feb;8(1):51-7. (PMID: 13521)
CNS Neurosci Ther. 2014 Dec;20(12):1045-55. (PMID: 25230377)
Nat Med. 2011 Apr;17(4):439-47. (PMID: 21475241)
Oncogene. 2003 Jul 24;22(30):4734-44. (PMID: 12879018)
Circulation. 1996 Sep 1;94(5):939-45. (PMID: 8790029)
Nat Commun. 2019 Mar 21;10(1):1318. (PMID: 30899013)
Neurology. 2021 Nov 16;97(20 Suppl 2):S6-S16. (PMID: 34785599)
JAMA. 1995 Oct 4;274(13):1017-25. (PMID: 7563451)
Immunity. 2014 Oct 16;41(4):518-28. (PMID: 25367569)
Neuropharmacology. 2008 Sep;55(3):334-44. (PMID: 18402985)
Stem Cell Reports. 2017 Apr 11;8(4):894-906. (PMID: 28344002)
Neuroscientist. 2019 Aug;25(4):334-343. (PMID: 30122106)
Front Physiol. 2019 Jan 18;10:2. (PMID: 30713499)
Toxicol Lett. 2008 Feb 15;176(3):188-97. (PMID: 18191348)
J Neurochem. 2013 Oct;127(2):221-32. (PMID: 23815397)
Mol Cell. 2020 Feb 20;77(4):901-912.e9. (PMID: 32001105)
Cell Death Dis. 2022 Feb 8;13(2):132. (PMID: 35136038)
Immunol Rev. 2012 Sep;249(1):43-58. (PMID: 22889214)
Nature. 2014 Nov 20;515(7527):431-435. (PMID: 25383517)
Nat Cell Biol. 2018 Jul;20(7):745-754. (PMID: 29950572)
Neuroscience. 1997 Mar;77(1):283-90. (PMID: 9044393)
Commun Biol. 2022 Jan 11;5(1):35. (PMID: 35017668)
Curr Biol. 2012 Jan 10;22(1):R29-34. (PMID: 22240478)
J Cereb Blood Flow Metab. 1994 Nov;14(6):892-902. (PMID: 7929654)
Nat Commun. 2022 Feb 17;13(1):945. (PMID: 35177618)
Cent Nerv Syst Agents Med Chem. 2011 Jun 1;11(2):98-106. (PMID: 21521170)
J Cereb Blood Flow Metab. 2016 Dec;36(12):2044-2050. (PMID: 27733676)
Cell. 2008 Dec 12;135(6):1074-84. (PMID: 19062087)
Cell Metab. 2019 Sep 3;30(3):493-507.e6. (PMID: 31257151)
Oncogene. 2015 Nov 19;34(47):5796-806. (PMID: 25867066)
Int J Mol Sci. 2019 Jul 31;20(15):. (PMID: 31370282)
J Biol Chem. 2009 Jan 30;284(5):3001-3011. (PMID: 19033437)
Protoplasma. 2020 Mar;257(2):335-343. (PMID: 31612315)
J Neurosci. 1998 Aug 15;18(16):6241-53. (PMID: 9698317)
Metab Brain Dis. 2004 Dec;19(3-4):151-67. (PMID: 15554412)
Neuron. 2012 Apr 26;74(2):277-84. (PMID: 22542182)
J Cereb Blood Flow Metab. 2011 Jan;31(1):17-35. (PMID: 21045864)
Neuroreport. 1993 Jun;4(6):709-11. (PMID: 8347812)
J Biochem. 2016 Apr;159(4):379-85. (PMID: 26839319)
Nature. 2013 Apr 11;496(7444):238-42. (PMID: 23535595)
J Biol Chem. 2008 Apr 18;283(16):10892-903. (PMID: 18281291)
Stroke. 2007 Feb;38(2 Suppl):770-3. (PMID: 17261736)
Cerebrovasc Brain Metab Rev. 1996 Fall;8(3):195-208. (PMID: 8870974)
Cell Rep. 2021 Dec 7;37(10):110102. (PMID: 34879266)
Neuron. 1999 Jun;23(2):297-308. (PMID: 10399936)
Brain. 2022 Mar 29;145(1):305-323. (PMID: 35022692)
J Comp Neurol. 2000 Nov 20;427(3):340-50. (PMID: 11054697)
J Cereb Blood Flow Metab. 2020 Jun;40(6):1137-1147. (PMID: 32153235)
Redox Biol. 2018 Jun;16:263-275. (PMID: 29549824)
Stroke. 2007 Feb;38(2 Suppl):674-6. (PMID: 17261713)
Stroke. 2022 May;53(5):1438-1448. (PMID: 35341322)
Nat Commun. 2019 May 9;10(1):2123. (PMID: 31073180)
Nat Med. 2011 Jul 07;17(7):796-808. (PMID: 21738161)
Front Cell Neurosci. 2021 Jun 08;15:605030. (PMID: 34168538)
Cell Death Differ. 2021 Jan;28(1):108-122. (PMID: 33162554)
Nat Rev Dis Primers. 2019 Oct 10;5(1):70. (PMID: 31601801)
Biochim Biophys Acta. 2010 Jun-Jul;1797(6-7):865-77. (PMID: 20175987)
Nat Med. 2009 Feb;15(2):192-9. (PMID: 19169263)
Annu Rev Physiol. 2016;78:23-44. (PMID: 26474213)
J Biol Chem. 2017 Jan 20;292(3):762-770. (PMID: 27920202)
J Cereb Blood Flow Metab. 2019 Oct;39(10):1906-1918. (PMID: 30523715)
Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1518-23. (PMID: 22233811)
Immunity. 2013 Apr 18;38(4):633-43. (PMID: 23601682)
Cell Death Differ. 2018 Jan;25(1):65-80. (PMID: 29149100)
Nature. 2010 Nov 11;468(7321):232-43. (PMID: 21068832)
Nat Rev Immunol. 2012 Apr 20;12(5):325-38. (PMID: 22517423)
Cell Metab. 2022 Sep 6;34(9):1248-1263.e6. (PMID: 35987203)
Front Physiol. 2014 Jul 31;5:282. (PMID: 25132820)
Int J Mol Sci. 2021 Aug 31;22(17):. (PMID: 34502395)
Elife. 2021 Feb 08;10:. (PMID: 33555254)
J Leukoc Biol. 2005 Dec;78(6):1223-32. (PMID: 16204625)
Nature. 2018 Apr;556(7701):332-338. (PMID: 29643512)
Cell. 2019 Jun 13;177(7):1682-1699. (PMID: 31199916)
J Exp Med. 1997 Apr 21;185(8):1481-6. (PMID: 9126928)
Biochim Biophys Acta Mol Basis Dis. 2017 Sep;1863(9):2307-2318. (PMID: 28634116)
Br J Pharmacol. 2014 Apr;171(8):2067-79. (PMID: 24032601)
Nat Rev Immunol. 2019 May;19(5):273-281. (PMID: 30705422)
Nat Neurosci. 2020 Feb;23(2):194-208. (PMID: 31959936)
Front Aging Neurosci. 2022 Mar 03;14:785761. (PMID: 35309888)
Immunity. 2013 Feb 21;38(2):225-36. (PMID: 23415911)
J Neurosci. 1999 Sep 1;19(17):7241-8. (PMID: 10460230)
Nat Med. 2013 Mar;19(3):351-7. (PMID: 23435171)
J Exp Med. 2011 Jul 4;208(7):1367-76. (PMID: 21708926)
Cell Rep. 2015 Jul 7;12(1):102-115. (PMID: 26119735)
Genome Med. 2021 Mar 26;13(1):47. (PMID: 33771213)
Cell Death Dis. 2022 Jul 5;13(7):582. (PMID: 35790716)
Nature. 2014 Apr 3;508(7494):55-60. (PMID: 24670647)
Cell. 2016 Jul 28;166(3):624-636. (PMID: 27374331)
Oxid Med Cell Longev. 2016;2016:9761697. (PMID: 27774120)
Nat Rev Mol Cell Biol. 2018 Jun;19(6):365-381. (PMID: 29626215)
Acta Neuropathol Commun. 2020 Nov 9;8(1):189. (PMID: 33168089)
Nat Rev Neurosci. 2006 Jan;7(1):41-53. (PMID: 16371949)
Stroke. 2020 Oct;51(10):3156-3168. (PMID: 32897811)
Ann Neurol. 1982 May;11(5):491-8. (PMID: 7103425)
Curr Opin Cell Biol. 2006 Aug;18(4):453-9. (PMID: 16781135)
Ther Adv Neurol Disord. 2018 May 22;11:1756286418774254. (PMID: 29854002)
Cold Spring Harb Perspect Biol. 2015 Jan 05;7(1):a020412. (PMID: 25561720)
Nat Commun. 2016 Oct 25;7:13280. (PMID: 27779186)
Stroke. 2021 May;52(5):1809-1821. (PMID: 33874744)
Neuron. 2017 Sep 27;96(1):17-42. (PMID: 28957666)
Sci Rep. 2019 Jan 24;9(1):507. (PMID: 30679481)
PLoS Biol. 2019 Jun 10;17(6):e2004413. (PMID: 31181072)
Brain Res. 1999 Sep 25;842(2):277-86. (PMID: 10526124)
Nature. 2003 Aug 21;424(6951):952-6. (PMID: 12931191)
Front Cell Neurosci. 2017 Mar 09;11:63. (PMID: 28337127)
Sci Adv. 2021 Jan 20;7(4):. (PMID: 33523920)
Cell Chem Biol. 2017 Apr 20;24(4):493-506.e5. (PMID: 28392146)
Neuron. 2021 Jan 20;109(2):299-313.e9. (PMID: 33157003)
Mol Metab. 2020 Feb;32:122-135. (PMID: 32029222)
J Cereb Blood Flow Metab. 2000 Jul;20(7):1011-32. (PMID: 10908035)
Front Cell Dev Biol. 2021 Jul 28;9:703084. (PMID: 34395432)
Dis Model Mech. 2012 Nov;5(6):718-25. (PMID: 23115201)
Mol Cell. 2020 Dec 3;80(5):779-795.e10. (PMID: 33207181)
J Cereb Blood Flow Metab. 1992 Mar;12(2):193-203. (PMID: 1548292)
Front Cell Dev Biol. 2018 Oct 10;6:132. (PMID: 30364203)
Stroke. 1996 Sep;27(9):1641-6; discussion 1647. (PMID: 8784142)
Cytokine Growth Factor Rev. 2017 Jun;35:63-70. (PMID: 28363691)
Immunol Rev. 2022 Oct;311(1):112-129. (PMID: 35481573)
Can J Neurol Sci. 2022 Nov;49(6):741-745. (PMID: 34526172)
Brain. 2022 Apr 18;145(2):542-554. (PMID: 34927673)
Nat Rev Neurol. 2012 Jun 05;8(7):401-10. (PMID: 22664787)
J Pathol. 2010 May;221(1):3-12. (PMID: 20225336)
Brain Res Bull. 2018 Sep;142:63-77. (PMID: 29964088)
J Immunol. 2012 Nov 1;189(9):4405-16. (PMID: 23024271)
Sci Rep. 2020 Feb 19;10(1):2990. (PMID: 32076076)
Front Cell Neurosci. 2014 Aug 14;8:231. (PMID: 25177270)
Blood. 2022 Feb 24;139(8):1234-1245. (PMID: 34529778)
J Cell Biol. 2020 Jun 1;219(6):. (PMID: 32357219)
Autophagy. 2010 May;6(4):482-94. (PMID: 20400854)
Theranostics. 2021 May 3;11(14):6746-6765. (PMID: 34093851)
J Cereb Blood Flow Metab. 2011 Sep;31(9):1836-51. (PMID: 21731034)
Exp Cell Res. 2016 Jan 15;340(2):315-26. (PMID: 26511505)
Med Res Rev. 2022 Jan;42(1):259-305. (PMID: 33957000)
Trends Neurosci. 2013 Oct;36(10):587-97. (PMID: 23968694)
Cell. 2011 May 27;145(5):732-44. (PMID: 21620138)
Science. 2018 May 18;360(6390):751-758. (PMID: 29700228)
Nat Immunol. 2008 Nov;9(11):1261-9. (PMID: 18820681)
Neuron. 2017 Nov 1;96(3):651-666. (PMID: 29096078)
J Cereb Blood Flow Metab. 2006 Jul;26(7):865-77. (PMID: 16407855)
Cell Metab. 2016 Jul 12;24(1):158-66. (PMID: 27374498)
Am J Transplant. 2016 Sep;16(9):2741-6. (PMID: 26999803)
Transl Stroke Res. 2020 Jun;11(3):337-344. (PMID: 31522408)
Neurocrit Care. 2022 Jun;37(Suppl 1):11-30. (PMID: 35194729)
Front Pharmacol. 2020 Oct 15;11:580343. (PMID: 33178023)
Neuroimage. 2019 Apr 1;189:171-179. (PMID: 30639333)
J Neurosci Res. 2009 Nov 1;87(14):3076-87. (PMID: 19479983)
Eur J Immunol. 2013 Apr;43(4):889-96. (PMID: 23310952)
Autophagy. 2021 Oct;17(10):3048-3067. (PMID: 33280500)
Curr Opin Neurobiol. 2016 Aug;39:152-63. (PMID: 27454347)
Nat Rev Immunol. 2016 Sep;16(9):553-65. (PMID: 27396447)
Cell. 2013 Jun 6;153(6):1239-51. (PMID: 23746840)
J Cereb Blood Flow Metab. 2001 Jan;21(1):2-14. (PMID: 11149664)
Physiol Rev. 2002 Jan;82(1):47-95. (PMID: 11773609)
Free Radic Biol Med. 2008 Jul 1;45(1):1-17. (PMID: 18423411)
Stroke. 1998 Oct;29(10):2189-95. (PMID: 9756602)
Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20364-71. (PMID: 24277826)
Science. 1989 Oct 20;246(4928):382-5. (PMID: 2799391)
Cell. 2004 Jan 23;116(2):205-19. (PMID: 14744432)
Free Radic Biol Med. 2009 Nov 15;47(10):1422-31. (PMID: 19699297)
J Nucl Med. 2017 Feb;58(2):187-193. (PMID: 27879370)
Nature. 2016 Jul 27;535(7613):551-5. (PMID: 27466127)
Neuroscience. 2017 Jun 23;354:1-10. (PMID: 28433650)
Free Radic Res. 2009 Apr;43(4):348-64. (PMID: 19241241)
Neuroscience. 2008 Sep 9;155(4):1204-11. (PMID: 18620031)
Elife. 2017 Jun 15;6:. (PMID: 28617241)
Exp Neurol. 1974 Nov;45(2):195-208. (PMID: 4424726)
Nat Rev Immunol. 2011 Jun;11(6):389-402. (PMID: 21597473)
Nat Neurosci. 2013 May;16(5):580-6. (PMID: 23542688)
J Neurosci. 1998 Jan 15;18(2):687-97. (PMID: 9425011)
J Neurochem. 2021 Aug;158(3):621-639. (PMID: 33608912)
Nat Rev Mol Cell Biol. 2020 Feb;21(2):85-100. (PMID: 31636403)
J Cereb Blood Flow Metab. 2009 Jun;29(6):1216-25. (PMID: 19352400)
Circ Res. 2022 Apr 15;130(8):1167-1186. (PMID: 35420915)
Neuron. 1995 Oct;15(4):961-73. (PMID: 7576644)
Acta Neuropathol. 1975 Aug 27;32(3):209-23. (PMID: 1180003)
Front Neurol. 2015 Apr 08;6:81. (PMID: 25904895)
Cell Metab. 2015 Jan 6;21(1):65-80. (PMID: 25565206)
Front Cardiovasc Med. 2022 Mar 09;9:861913. (PMID: 35355966)
Br J Cancer. 1972 Aug;26(4):239-57. (PMID: 4561027)
Oncotarget. 2015 Mar 30;6(9):6570-83. (PMID: 25788265)
Trends Neurosci. 1994 Jun;17(6):251-7. (PMID: 7521086)
Neurochem Res. 2019 Jul;44(7):1602-1612. (PMID: 30911983)
J Cereb Blood Flow Metab. 2012 Feb;32(2):353-67. (PMID: 21952111)
J Neurosci. 2012 Feb 1;32(5):1847-58. (PMID: 22302823)
Oncogene. 2008 Dec;27 Suppl 1:S53-70. (PMID: 19641507)
Neuron. 2012 May 24;74(4):719-30. (PMID: 22632729)
Autophagy. 2010 Nov;6(8):1107-14. (PMID: 20930570)
Front Neurol. 2017 Sep 07;8:467. (PMID: 28936196)
Mol Biol Cell. 2009 Apr;20(7):1992-2003. (PMID: 19225151)
EMBO J. 2020 May 18;39(10):e103111. (PMID: 32187724)
J Cell Biol. 1967 Jul;34(1):207-17. (PMID: 6033532)
J Pharmacol Sci. 2021 Sep;147(1):156-167. (PMID: 34294367)
Cell Metab. 2022 Apr 5;34(4):634-648.e6. (PMID: 35303422)
Stroke. 1995 Nov;26(11):2120-6. (PMID: 7482660)
J Cell Biol. 2010 Apr 5;189(1):83-94. (PMID: 20351066)
Mol Cell. 2019 Jan 17;73(2):354-363.e3. (PMID: 30581146)
Can J Neurol Sci. 1987 Nov;14(4):557-9. (PMID: 2446732)
Acta Neuropathol Commun. 2020 Mar 20;8(1):36. (PMID: 32197663)
Cell Biosci. 2020 Jun 15;10:79. (PMID: 32549974)
Methods Cell Biol. 2021;164:167-185. (PMID: 34225914)
Cell Death Differ. 2017 Feb;24(2):317-329. (PMID: 27935582)
J Cell Biol. 2015 Aug 31;210(5):705-16. (PMID: 26323688)
Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20491-6. (PMID: 23185017)
Microvasc Res. 2004 Nov;68(3):231-8. (PMID: 15501242)
Neuroimage. 2020 Jan 1;204:116202. (PMID: 31557546)
Glia. 2016 May;64(5):810-25. (PMID: 26775288)
Neurocrit Care. 2022 Jun;37(Suppl 1):83-101. (PMID: 35257321)
J Neuroinflammation. 2020 Nov 5;17(1):329. (PMID: 33153476)
Immunity. 2022 Jan 11;55(1):14-30. (PMID: 35021054)
Neuron. 2015 Mar 04;85(5):1117-31. (PMID: 25741731)
J Neurosci. 2016 Apr 27;36(17):4698-707. (PMID: 27122029)
Nature. 2015 Aug 20;524(7565):309-314. (PMID: 26266977)
Neurosci Lett. 2001 Nov 16;314(3):135-8. (PMID: 11704302)
Nat Rev Immunol. 2017 Dec;17(12):774-785. (PMID: 28972206)
J Neurosci. 2012 Jan 11;32(2):583-92. (PMID: 22238093)
Front Neurosci. 2019 Jun 19;13:637. (PMID: 31275110)
Physiol Rev. 2018 Apr 1;98(2):813-880. (PMID: 29488822)
J Neurosci. 2001 Oct 1;21(19):7724-32. (PMID: 11567062)
Cell Metab. 2016 Feb 9;23(2):254-63. (PMID: 26777689)
J Cell Biol. 2018 Jul 2;217(7):2235-2246. (PMID: 29752396)
Mol Cell. 2014 Feb 20;53(4):521-33. (PMID: 24462113)
Elife. 2018 Jan 25;7:. (PMID: 29368690)
Trends Pharmacol Sci. 2021 Feb;42(2):96-105. (PMID: 33341247)
PLoS Biol. 2008 Jun 10;6(6):e147. (PMID: 18547146)
Neuron. 2015 May 20;86(4):883-901. (PMID: 25996133)
Autophagy. 2021 Jun;17(6):1519-1542. (PMID: 33111641)
FASEB J. 2007 Nov;21(13):3666-76. (PMID: 17586731)
EMBO Rep. 2016 Dec;17(12):1721-1730. (PMID: 27856534)
Nat Rev Mol Cell Biol. 2020 Aug;21(8):439-458. (PMID: 32372019)
J Mol Neurosci. 2018 Oct;66(2):238-250. (PMID: 30203298)
Vasc Cell. 2013 Apr 20;5:8. (PMID: 23601533)
Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):E4098-107. (PMID: 24101459)
Mol Cell. 2004 Dec 3;16(5):819-30. (PMID: 15574336)
Brain Pathol. 2020 Nov;30(6):1208-1218. (PMID: 33058417)
فهرسة مساهمة: Keywords: Apoptosis; Autophagy; Cell death; Glucose metabolism; Mitochondria; Neuroinflammation; Penumbra; Stroke
المشرفين على المادة: IY9XDZ35W2 (Glucose)
S88TT14065 (Oxygen)
تواريخ الأحداث: Date Created: 20221011 Date Completed: 20230824 Latest Revision: 20230919
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC10444697
DOI: 10.1007/s12975-022-01090-9
PMID: 36219377
قاعدة البيانات: MEDLINE
الوصف
تدمد:1868-601X
DOI:10.1007/s12975-022-01090-9